BSECompany Update6 Oct 2026 · 6 Oct 2026, 03:27 pm

Please find enclosed herewith the certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended September 30, 2026.

Bliss GVS Pharma Ltd · 506197

✦ AI SummaryResults

Bliss GVS Pharma Ltd has received a certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended September 30, 2026, confirming the dematerialisation of securities and listing on stock exchanges.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bliss GVS Pharma Ltd - 506197 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

7ce27609-eee6-4ad0-bce8-13897f9c7b04.pdf

pdf

Download →
View document text
October 06, 2026 To To The Manager, Listing Department The General Manager, Listing Department National Stock Exchange of India Limited BSE Limited Plot no. C/1 G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai- 400 051 Mumbai- 400 001 Symbol: BLISSGVS Scrip Code: 506197 Dear Sir/Madam, Subject: Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026 Please find enclosed herewith a certificate received from MUFG Intime India Private Limited (Formerly known as Link Intime India Private Limited), Registrar and Share Transfer Agent of the Company under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026. Kindly take the same on record. Thanking you. For Bliss GVS Pharma Limited Aditi Bhatt Company Secretary Encl: a/a National Securities Depository Limited Central Depository Services (India) Ltd. 3rd Floor, Naman Chamber, Plot C-32, G- Marathon Futurex, A-Wing, 25th floor, N Block, Bandra Kurla Complex, Bandra East, M Joshi Marg, Lower Parel, Mumbai Mumbai, Maharashtra - 400 051 400013 MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) CIN: U67190MH1999PTC118368 Registered Address: C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai - 400083. Tel: +91 22 4918 6000 www.in.mpms.mufg.com Date : 03-10-2026 The Compliance Officer/ Company Secretary BLISS GVS PHARMA LIMITED 102 HYDE PARK SAKI VIHAR ROAD ANDHERI EAST MUMBAI MUMBAI PINCODE : 400072 Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. Dear Sir/Madam, In reference to the above captioned regulation, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended 30th September 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed. We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) Ashok Shetty Sr. Vice President-Corporate Registry MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services